Skip to main content
. Author manuscript; available in PMC: 2018 May 22.
Published in final edited form as: Breast Cancer Res Treat. 2015 Aug 7;153(1):201–209. doi: 10.1007/s10549-015-3527-8

Table 4.

Different characteristics between women tested found to have deleterious mutations and women tested without deleterious mutations

Characteristics BRCA1/2 mutations
(n = 15) N (%)
Genetic testing and no deleterious
mutation (n = 105) N (%)
p valuea
Age at diagnosis
  Mean 40.9 47.5 0.03
Significant family historyb 11 (73.3) 43 (41.0) 0.02
TNBC 6 (40.0) 20 (19.0) 0.03
Hormone receptor positive 5 (25.0) 67 (63.8) 0.06
a

Comparing women tested with mutations to women tested and without a deleterious mutation

b

Defined as the presence of at least one FDR or SDR affected with breast cancer diagnosed before age 50 or with ovarian cancer at any age